8-K Filing Summary

This 8-K filing reports on the 2026 Annual Meeting of Stockholders of RxSight, Inc., held on June 16, 2026. The meeting saw approximately 80.4% of the outstanding common stock represented. Key outcomes include the re-election of three Class II Directors: William J. Link, Robert Warner, and Shweta Singh Maniar. Additionally, stockholders approved, on an advisory basis, the compensation of the named executive officers. The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified. The filing includes detailed voting results for each matter.